CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AngioLab Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AngioLab Inc
122, 159, 65, Techno 3-ro, Yuseong-gu
Phone: +82 428675785p:+82 428675785 DAEJEON, 34016  South Korea Ticker: 251280251280

Business Summary
AngioLab, Inc. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the manufacturing and sale of pharmaceuticals and functional health food. The pharmaceuticals include obesity treatment, retinopathy treatment, periodontal disease treatments, otitis media treatments, and psoriasis treatments. The functional health food include visceral fat reducing health functional food named Obi-X. In addition, the Company is engaged in the manufacturing and sale of anti-wrinkle cosmetics and deep-sea beard toothpastes. The Company distributes its products within the domestic market and to overseas markets, including America, Europe and Australia.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201812/31/2018Yes----

General Information
Outstanding Shares: 1,925,914 (As of 7/19/2019)
Stock Exchange: KON
Fax Number: +82 428675787


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, December 11, 2019